Diabetes Board decisions

The Board has decided to remand the claims for service connection for diabetes mellitus and coronary artery disease due to incomplete service personnel records, which may provide evidence of herbicide agent exposure.

The Veteran's bilateral hearing loss and service-connected disabilities have not met the criteria for a disability rating in excess of 10 percent prior to November 16, 2022 or entitlement to TDIU prior to that date.

The Board has remanded several issues related to the Veteran's claims, including service connection for various conditions and reopening of previously denied claims. The main issue is that there is insufficient evidence to determine if any of these conditions had onset during or are otherwise related to service.

The Board has decided to remand the claims for service connection for diabetes mellitus and hypertension due to a lack of development, including obtaining VA medical opinions on the etiology of these conditions.

The Board has remanded the case due to conflicting medical evidence regarding the nature and etiology of the Veteran's upper extremity symptoms, including numbness and tingling. An additional VA examination is needed to determine if these symptoms are related to his service-connected diabetes mellitus.

The Veteran's appeal has been dismissed due to his death. The Board cannot proceed with the merits of the claims as they are no longer relevant.

Service connection for diabetes mellitus type II, presumed due to herbicide exposure is granted. The issues of peripheral neuropathy are remanded.

The Veteran's ratings for Ischemic heart disease, Psoriasis, and Diabetes mellitus, type II are restored or maintained at 60 percent each. The Veteran is denied a higher rating for Ischemic heart disease prior to February 15, 2022, and the claim for total disability based on individual unemployability due to service-connected disabilities is denied.

The Board has remanded several issues related to the Veteran's service connection claims, including for diabetes mellitus, Type II, neuropathy of the feet, and right knee arthritis. The rating for left elbow strain with bursitis is also being remanded.

The Veteran's appeals for an evaluation in excess of 10 percent for cirrhosis with chronic cholelithiasis and entitlement to service connection for diabetes mellitus, type II have been dismissed due to the appellant's withdrawal of his appeal.

The Veteran's diabetes mellitus, type II and hypertension have been granted service connection based on the PACT Act presumption of exposure to herbicide agents. The right hand neurological disability, left hand neurological disability, skin disability (including melanoma, multiple myeloma, and nevus), organic disease of the central nervous system (previously claimed as residuals of a stroke), and respiratory disorder (including asthma and chronic cough) have been remanded for further development.

The Board has remanded the claims of service connection for endocarditis, lung cancer, diabetes mellitus, renal condition, bilateral lower extremity condition, bilateral eye condition, and osteoporosis due to unresolved medical issues and lack of a VA examination.

The Veteran's TDIU and SMC at the housebound rate are granted. The Board also remanded for further examination to determine if the Veteran's diabetes is secondary to his PTSD.,Service connection for type II diabetes mellitus remains pending, with a new VA examination required.

The Board has remanded the cases due to insufficient evidence regarding the Veteran's exposure in or near the Korean DMZ, which is required for presumptive service connection.

The Board denied the Veteran's claims for service connection for the cause of his death and for DIC under 38 U.S.C. § 1318, finding that there was no evidence to support a finding that any of the conditions on the death certificate were related to service.

The Board has remanded the claims of service connection for diabetes mellitus, type II, hypertension, and a heart disability (including CAD with CABG) due to their association with the Veteran's service-connected asbestosis. The VA will provide new examinations to determine if these conditions are related to or aggravated by the service-connected condition.

The Board denied the Veteran's claim for service connection for diabetes mellitus, type II as secondary to statin medication prescribed for his service-connected coronary artery disease. The evidence did not support a finding that the statins caused the Veteran's DMII.

The Veteran's appeals for a compensable rating for hypertension, an evaluation in excess of 40 percent for diabetes mellitus, type II, and entitlement to a total disability rating based on individual unemployability (TDIU) have been dismissed due to the appellant's withdrawal of these appeals.

The Board has denied the claims for service connection for diabetes mellitus and lung cancer, finding no evidence of in-service onset or exposure to herbicide agents.

The Board granted service connection for Type II Diabetes Mellitus, Hypertension, and Kidney Disease due to exposure to herbicide agents during active duty in Guam. The effective date is not specified as it falls under the PACT Act's presumptive exposure period.